Detalhe da pesquisa
1.
The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells.
Nature
; 616(7956): 348-356, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37020026
2.
Publisher Correction: The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells.
Nature
; 618(7964): E17, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37198495
3.
Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals.
J Infect Dis
; 225(7): 1124-1128, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34792136
4.
Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.
N Engl J Med
; 388(6): 565-567, 2023 02 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36630611
5.
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.
N Engl J Med
; 387(1): 86-88, 2022 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35731894
6.
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
N Engl J Med
; 386(16): 1579-1580, 2022 04 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35294809
7.
Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines.
N Engl J Med
; 385(21): 2010-2012, 2021 11 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34648703
8.
Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1.
Vaccine
; 42(9): 2117-2121, 2024 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38458874
9.
Waning immunity and IgG4 responses following bivalent mRNA boosting.
Sci Adv
; 10(8): eadj9945, 2024 Feb 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38394195
10.
Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters.
bioRxiv
; 2023 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36747640
11.
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86.
Vaccine
; 41(47): 6904-6909, 2023 11 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37872011
12.
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
medRxiv
; 2022 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35169817
13.
Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters.
bioRxiv
; 2022 Oct 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36324798
14.
Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant.
Sci Transl Med
; 14(641): eabn6150, 2022 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35258323
15.
Durability of Heterologous and Homologous COVID-19 Vaccine Boosts.
JAMA Netw Open
; 5(8): e2226335, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35947380
16.
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts.
medRxiv
; 2021 Oct 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34704104